9 related news articles for Archived: Pancreatic cancer
-
US Defense Dept backs Aussie upper gastrointestinal cancer research
If an army marches on its stomach, as the old saying goes, then the US Department of Defense (DoD) is investing wisely in Australian upper gastrointestinal cancer research.… Read more
-
Never stop asking – hope for pancreatic cancer patients
Pancreatic cancer is predicted to be the second leading cause of cancer-related death by 2030. While other cancer survival rates are improving, pancreatic cancer has been virtually unchanged for four decades.… Read more
-
Big benefits in detection and treatment of pancreatic cancer
Researchers looking into one of the deadliest forms of cancer have made a big breakthrough by drilling down to the molecular level.… Read more
-
Researchers receive collaboration grant from PanKind to expand targeted screening for pancreatic cancer
Hudson Institute researchers Dr Daniel Croagh and Professor Brendan Jenkins have received a share of the Australian Pancreatic Cancer Foundation’s (PanKind) 2020 Collaborative Research Grant to help accelerate… Read more
-
Pancreatic cancer funding boost
Congratulations to Professor Brendan Jenkins and his team, who have been awarded $288,536 from Cancer Council Victoria (CCV) to fund research into pancreatic cancer.… Read more
-
Mistaken identity: new mechanism behind stomach cancer identified
Improved treatments for a range of cancers could be possible following a discovery that stomach cancer is mainly driven by a different process than previously believed.… Read more
-
Harnessing immune therapies to combat pancreatic cancer
Investigating the role of the immune system in the fight against pancreatic cancer is the focus of innovative research at Hudson Institute, thanks to new funding announced on World Pancreatic Cancer Day.… Read more
-
Precision medicine pipeline may improve drug treatment for pancreatic cancer
A team of scientists and clinicians in Clayton, Melbourne, has optimised a non-invasive technique to screen pancreatic cancer patients for responsiveness to specific drugs, and has commenced a trial with a drug currently used to treat colon cancer in the hope it may be effective in treating up to 10 per cent of pancreatic cancer patients.… Read more
-
CASS Foundation supports three Hudson Institute research projects
Four Hudson researchers have been awarded grants totalling more than $160,000 by the CASS Foundation to further their research projects into pancreatic cancer, muscle wasting diseases and developing female contraceptives. CASS Foundation is a private philanthropic organization that supports Victorian medicine and science research projects that have the potential to lead to improved treatment and practice. Professor Brendan Jenkins, from Hudson’s Centre for Innate Immunity and Infectious… Read more